ORTHOPEDIATRICS CORP
For the period ended Dec 31, 2023. Filed Mar 8, 2024.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2023 · Filed Mar 8, 2024
KIDS$33.48-1.5%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Item 9C. Disclosure Regarding Foreign Jurisdictions that Prevent Inspections
| PART III | ||
|---|---|---|
| Item 10. | Directors, Executive Officers and Corporate Governance | 120 |
| Item 11. | Executive Compensation | 120 |
| Item 12. | Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters | 120 |
| Item 13. | Certain Relationships, Related Transactions and Director Independence | 120 |
| Item 14. | Principal Accountant Fees and Services | 120 |
| PART IV | ||
| Item 15. | Exhibits and Financial Statement Schedules | 121 |
Glossary of Acronyms and Defined Terms
| ACL | Anterior cruciate ligament |
|---|---|
| ApiFix | The combination of ApiFix, Ltd and ApiFix, Inc., which were acquired by the Company April 1, 2020 |
| Approved Body | An approved body under UK medical Device Regulations |
| Band-Lok | Band-Lok, LLC, which sold certain intellectual property assets to the Company on June 10, 2020 |
| CE Mark | Conformite Europeene Mark used for medical devices in the EEA; a product with such a mark is referred to herein as a "CE-Marked" product. |
| CME | Continuing medical education |
| CMS | Centers for Medicare and Medicaid Services |
| Company | OrthoPediatrics Corp. |
| Credit Agreement | Credit, Security and Guaranty Agreement with MidCap Financial Trust, as amended from time to time, which provides the Company with a $50 million line of credit and a $30 million term loan |
| Devise Ortho | Devise Ortho, Inc. which sold certain assets and intellectual property to the Company on October 20, 2021 |
| DHHS | U.S. Department of Health and Human Services |
| EEA | European Economic Area |
| EU | European Union |
| Exchange Act | U.S. Securities Exchange Act of 1934 |
| FDA | U.S. Food and Drug Administration |
| FDASIA | Food and Drug Administration Safety and Innovation Act |
| FDCA | Federal Food, Drug and Cosmetic Act |
| FERA | Fraud Enforcement Recovery Act of 2009 |
| Foundation | The Foundation for Advancing Pediatric Orthopedics |
| GAAP | U.S. Generally Accepted Accounting Principles |
| GDPR | EU General Data Protection Regulation |
| HCP | Healthcare providers |
| HDE | Humanitarian Device Exemption under FDA regulation |
| HIPAA | Health Insurance Portability and Accountability Act of 1996 |
| IPO | Company’s initial public offering of its common stock on October 11, 2017 |
| IRB | Institutional Review Board utilized by the FDA |
| LLD | Limb length discrepancies |
| MDD | Medical Devices Directive |
| MD Ortho or MDO | MD Orthopaedics, which was acquired by the Company on April 1, 2022 |
| MDR | EU’s Medical Device Regulation |
| MHRA | Medicines and Healthcare products Regulatory Agency of the United Kingdom |
| MPFL | Medial petellofemoral ligament |
| Orthex | Orthex, LLC, which was acquired by the Company on June 4, 2019 |
| PMA | Premarket Approval Application with the FDA |
| Pega Medical or Pega | Pega Medical Inc., which was acquired by the Company on July 1, 2022 |
| POD | Physician-owned distributorships |
| POSNA | Pediatric Orthopaedic Society of North America |
| QSR | FDA’s Quality System Regulation |
| RSV | Respiratory Syncytial Virus, a respiratory virus commonly impacting children |
| SEC | United States Securities and Exchange Commission |
|---|---|
| Squadron | Squadron Capital LLC, which is the Company’s largest investor |
| Loan Agreement | Fourth Amended and Restated Loan and Security Agreement with Squadron Capital LLC (terminated effective as of December 29, 2023), which provided the Company with a $50.0 million revolving credit facility |
| Structure Medical | Structure Medical, LLC |
| Telos | Telos Partners, LLC, which was acquired by the Company on March 9, 2020 |
| UK or United Kingdom | The United Kingdom of Great Britain and Northern Ireland |
| UKCA Mark | UK Conformity Assessed marking is a new UK product marking that is used for goods being placed on the market in Great Britain (England, Wales and Scotland) |
| Vilex | Vilex in Tennesee, Inc., which was acquired by the Company on June 4, 2019 and substantially all its assets were sold on December 31, 2019 to a wholly-owned subsidiary of Squadron Capital, LLC |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.